Get started
Orthocell LtdOrthocell LtdOrthocell Ltd

Orthocell Ltd

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪181.85 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.023607 USD
Net income (FY)
‪−5.63 M‬ USD
Revenue (FY)
‪4.97 M‬ USD
Shares float
‪220.43 M‬
Beta (1Y)
1.91

About Orthocell Ltd


Sector
Health Technology
Industry
Medical Specialties
CEO
Paul Frederick Anderson
Website
orthocell.com
Headquarters
Murdoch
Founded
2006
ISIN
AU000000OCC6
FIGI
BBG00GFRXDQ5
Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. Its products include CelGro, which is a naturally derived collagen medical device for soft tissue repair; and Antilogous Tenocyte Implantation for chronic treatment resistant tendon injuries. The company was founded by Paul Frederick Anderson and Ming Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Check out other big names from the same industry as ORHHF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


ISCF
iShares International SmallCap Equity Factor ETF
Weight
0.04%
Market value
‪237.94 K‬
USD

Explore more ETFs 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Orthocell Ltd stocks are traded under the ticker ORHHF.
We've gathered analysts' opinions on Orthocell Ltd future price: according to them, ORHHF price has a max estimate of 0.88 USD and a min estimate of 0.88 USD. Watch ORHHF chart and read a more detailed Orthocell Ltd stock forecast: see what analysts think of Orthocell Ltd and suggest that you do with its stocks.
Yes, you can track Orthocell Ltd financials in yearly and quarterly reports right on TradingView.
Orthocell Ltd is going to release the next earnings report on Mar 3, 2026. Keep track of upcoming events with our Earnings Calendar.
ORHHF net income for the last half-year is ‪−4.78 M‬ USD, while the previous report showed ‪−801.85 K‬ USD of net income which accounts for −496.25% change. Track more Orthocell Ltd financial stats to get the full picture.
No, ORHHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Orthocell Ltd EBITDA is ‪−8.47 M‬ USD, and current EBITDA margin is −170.59%. See more stats in Orthocell Ltd financial statements.
Like other stocks, ORHHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Orthocell Ltd stock right from TradingView charts — choose your broker and connect to your account.